SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)

CUSIP: 85205L107

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $.0001 per share
Shares outstanding
75,607,738
Total 13F shares
80,867,369
Share change
-4,169,513
Total reported value
$2,921,793,248
Put/Call ratio
149%
Price per share
$36.13
Number of holders
214
Value change
-$118,091,155
Number of buys
115
Number of sells
107

Security key

85205L107

Report period

Q4 2024

Institutions

214

Top holders

10

Top shareholders of SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13D/G 13F
The Vanguard Group · Company
9.6%
7,158,871
$331,026,195 $0 31 Dec 2024
Deep Track Capital, LP
13D/G 13F
Company
4.6%
3,460,756
$160,025,357 $0 31 Dec 2024
FMR LLC
13F
Company
15%
11,140,946
$356,955,910 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
7.9%
5,941,797
$190,375,177 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
4.7%
3,516,418
$112,667,000 30 Sep 2024
13F
Boxer Capital, LLC
13F
Company
4.5%
3,421,541
$109,626,174 30 Sep 2024
13F
STATE STREET CORP
13F
Company
4.1%
3,090,552
$99,021,286 30 Sep 2024
13F
MAVERICK CAPITAL LTD
13F
Company
3.7%
2,778,348
$89,018,270 30 Sep 2024
13F
MARSHALL WACE, LLP
13F
Company
2.6%
1,961,830
$62,857,035 30 Sep 2024
13F
Pictet Asset Management Holding SA
13F
Company
2.5%
1,925,918
$61,707,910 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.2%
1,670,247
$53,525,542 30 Sep 2024
13F
Polar Capital Holdings Plc
13F
Company
2%
1,500,000
$48,060,000 30 Sep 2024
13F
ArrowMark Colorado Holdings LLC
13F
Company
2%
1,492,062
$47,805,666 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
1.9%
1,438,635
$46,093,873 30 Sep 2024
13F
ORBIMED ADVISORS LLC
3/4/5 13F
10%+ Owner · Company
1.8%
from 13F
5,599,842
$232,561,438 12 Sep 2022
Woodline Partners LP
13F
Company
1.8%
1,381,624
$44,267,233 30 Sep 2024
13F
Siren, L.L.C.
13F
Individual
1.8%
1,377,701
$44,141,540 30 Sep 2024
13F
Fiera Capital Corp
13F
Company
1.7%
1,257,964
$40,305,167 30 Sep 2024
13F
Capital International Investors
13F
Company
1.6%
1,225,667
$39,270,371 30 Sep 2024
13F
LORD, ABBETT & CO. LLC
13F
Company
1.4%
1,069,738
$34,274,000 30 Sep 2024
13F
GW&K Investment Management, LLC
13F
Company
1.2%
925,361
$29,648,000 30 Sep 2024
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
1.2%
918,445
$29,427,000 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
1.1%
861,210
$27,593,167 30 Sep 2024
13F
S.c.a. Candriam
13F
Individual
1.1%
845,170
$27,078,034 30 Sep 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
1.1%
797,877
$25,563,984 30 Sep 2024
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.96%
729,125
$23,361,165 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.96%
725,117
$23,233,279 30 Sep 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
0.96%
724,682
$23,218,812 30 Sep 2024
13F
Duquesne Family Office LLC
13F
Company
0.93%
705,066
$22,590,000 30 Sep 2024
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.92%
692,263
$22,180,107 30 Sep 2024
13F
Finepoint Capital LP
13F
Company
0.86%
650,852
$20,853,298 30 Sep 2024
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.85%
643,192
$20,607,872 30 Sep 2024
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.83%
629,387
$20,165,559 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.8%
602,770
$19,312,751 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.8%
602,227
$19,295,353 30 Sep 2024
13F
SOROS FUND MANAGEMENT LLC
13F
Company
0.74%
559,321
$17,920,645 30 Sep 2024
13F
Invesco Ltd.
13F
Company
0.69%
524,743
$16,812,765 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.56%
421,776
$13,513,703 30 Sep 2024
13F
Cutter Capital Management, LP
13F
Company
0.5%
378,453
$12,125,634 30 Sep 2024
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.48%
364,060
$11,664,482 30 Sep 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.43%
322,086
$10,319,635 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.39%
297,899
$9,544,683 30 Sep 2024
13F
Walleye Capital LLC
13F
Company
0.38%
286,093
$9,166,420 30 Sep 2024
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.38%
285,555
$9,149,182 30 Sep 2024
13F
Jefferies Financial Group Inc.
13F
Company
0.36%
275,000
$8,811,000 30 Sep 2024
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
0.36%
273,479
$9,295,551 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.34%
255,052
$8,171,867 30 Sep 2024
13F
NORGES BANK
13F
Company
0.31%
233,348
$7,476,470 30 Sep 2024
13F
Ally Bridge Group (NY) LLC
13F
Company
0.3%
227,700
$7,295,508 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.3%
226,928
$7,270,767 30 Sep 2024
13F

Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q4 2024

As of 31 Dec 2024, SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) was held by 214 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 80,867,369 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock, Inc., Deep Track Capital, LP, Boxer Capital Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, MAVERICK CAPITAL LTD, Pictet Asset Management Holding SA, and Capital International Investors. This page lists 214 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
224
Q4 2024 holders
214
Holder diff
-10
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .